5Treancr J J, Hayden FG,Vrooman PS,et al. Efficacy and safety of the oral neuraminidase inhibitor oscharnivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidane Study Group[J]. JAMA,2000,283:1016- 1 024.
6Nicholson KG,Aoki FY,Osterhaus AD,et al. Efieaey and safety of osehamivir in treatment of acute influenza:a randomized controlled trial. Neuraminidase Inhibitor Flu Treatment lm, estigator Group[J]. Lancet, 2000,355:1 845 - 1 850.
7Oo C,Barrett J,Hill G,et al. Pharmaeokinetics and dosage recommendations for an osehamivir oral suspension for treatment of influenza in children [ J ]. Paediatr Drugs, 2001,3 (3) : 229 - 235.
8Snell P,Oo C,Dorr A,et al. I,ack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids[J]. Br J Clin Pharmaco,2002,54(4) :372 -376.
9Treanor JJ, Hayden FG, Vromnan PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltan-,ivir in treating acute influenza[ J ]. JAMA, 2000, 283(8) :1016.
7SIDWELL R W, SMEE D F. Peramivir(BCX-1812.RWJ- 270201): potential new therapy for influenza [J]. Expert Opin Investig Drugs, 2002, 11(6): 859-869.
8ALFRED S S, CHRISTOPHER J, WENDY C, et al. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza a virus [J]. Clin Infect Dis, 2012, 55(1): 1-7.
9GOVORKOVA E A, LENEVA I A, GOLOUBEVA O G, et al. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses [J]. Antimicrob Agents Chemother, 2001, 45(10): 2723-2732.
10RENEGAR K B, SMALL PA J R, BOYKINS LG, et al. Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract [J]. J Immunol, 2004, 173(3): 1978-1986.
